Brief: DSM-Firmenich Q1 Sales At EUR 2.28 Billion
06/05/2026 06:06
May 6 (Reuters) - DSM-Firmenich AG DSFIR.AS: DSM-FIRMENICH Q1 2026 TRADING UPDATE FY 2026 OUTLOOK MAINTAINED Q1 ADJUSTED EBITDA EUR 434 MILLION VERSUS EUR 431 MILLION IN COMPANY-COMPILED CONSENSUS 4% LFL SALES GROWTH IN Q1 TO DUAL LIST SHARES ON SIX SWISS EXCHANGE EFFECTIVE MAY 21, 2026 TO ACCELERATE EXECUTION IN 2026–2027 TO DRIVE GROWTH AND SYNERGIES, EXPAND EBITDA MARGINS, AND IMPROVE CASH CONVERSION Q1 SALES EUR 2.28 BILLION VERSUS EUR 2.25 BILLION IN COMPANY-COMPILED CONSENSUS Q1 2026 ADJUSTED EBITDA MARGIN AT 19.1% Source text: ID:nGNE4hfSX6 Further company coverage: DSFIR.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))